Weight loss drug Zepbound may help against sleep apnea, company says

Eli Lilly says it plans to submit its trial results to the U.S. Food and Drug Admin to possibly expand Zepbound's use for obstructive sleep apnea.

Next up in 5

Example video title will go here for this video

Next up in 5

Example video title will go here for this video

Eli Lilly says it plans to submit its trial results to the U.S. Food and Drug Admin to possibly expand Zepbound’s use for obstructive sleep apnea.

More Stories